Home
News
Latest News
People Moves
Business Briefs
Newsletters
Features
Features
Reprints
Surveys
Editorial Calendar
Issue Archive
Events
MM&M Awards 2012
Webcasts
MM&M Virtual Summit
Whitepapers
Directories
Pharmaceutical Marketers Directory
MM&M Service Directory
Agency Gallery
Direct Marketing Showcase
Medical Education Review
Sales Force Listings
Jobs
About Us
Subscriber Services
Contact Us
Media Information
Editorial Advisory Board
Drug Info
New Drug Dossier
Drug Database
Subscribe
Order Now
Subscriber Services
Newsletters
RSS
|
Login
|
Register
MMM
>
News
>
Business Briefs
> MEBN awarded four-year continuation of accreditation status
Med Ed Report
MEBN awarded four-year continuation of accreditation status
June 01, 2008
Print
Email
Reprint
Permissions
Text:
A
|
A
|
A
More Business Briefs
Company news: Amgen
Company news: Amgen
Company news: Santarus beefs up sales force, Physicians Interactive gets patent
Industry news: Lilly's salary cap; Hatch takes hatchet to medical device tax
Company news: Merck, Millennium, Novo Nordisk and Genentech
MEBN, a New Hampshire medical education and communications company, has been awarded a four-year continuation of its accreditation status by ACCME, which recognized the firm for excellence in its needs assessment and program evaluation criteria.
From the June 2008 Issue of MMM
Please enable JavaScript to view the
comments powered by Disqus.
MM&M Awards 2011 HIghlights
The Best MM&M Awards Ever!
MM&M Awards Photos
Most Popular
Most Emailed
Most Recent
Industry group releases digital best practices
Jobson Medical files for chapter 11 debt relief
AstraZeneca announces more layoffs, Q4 results
Komen, caught up in the culture wars, nurses damaged brand
Merck results buoyed by sales of Januvia franchise
Docs, patients and pharma
Allergan scrubs some doc-payment data, spares med-ed grants
Expanded use of Xgeva a longshot, analysts say
Pfizer promotes Canada chief to lead US primary care marketing
Amylin reports Q4 sales slump, touts Bydureon potential
Jobson Medical files for chapter 11 debt relief
Industry group releases digital best practices
Pfizer promotes Canada chief to lead US primary care marketing
Merck results buoyed by sales of Januvia franchise
Merck looks to wake up sleep aids category with suvorexant
White House sides with GSK sales reps
Merck, GSK shrug off rec to make HPV vaccine routine
Allergan scrubs some doc-payment data, spares med-ed grants
Sanofi braces for patent cliff impact
Expanded use of Xgeva a longshot, analysts say
Sanofi braces for patent cliff impact
Unemployment picture brightens for US, but not for pharmas
Pfizer promotes Canada chief to lead US primary care marketing
White House sides with GSK sales reps
Pharma had third-most layoffs in Jan 2012
Amylin reports Q4 sales slump, touts Bydureon potential
Digital think tank: Pharma Touchpoints
Case study—Nuvigil: Pay for Play
Gamification: Game On
Regulatory updates: First Glimmer of Guidance?
Popular Topics
Advertising
Approval
Brand
Corporate Reputation
DDMAC
Digital
Direct To Consumer (DTC)
DTC
Facebook
FDA
Financial
Generic
Guidance
Launch
Magazine
Major Statement
Manufacturing
Media
Medical Education
Off-label
Online
OPDP
Promotion
Social Media
Television